Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Automated Device Safety Surveillance Gets Proof Of Principle

This article was originally published in The Gray Sheet

Executive Summary

Comprehensively tracking post-market safety signals presents an almost insurmountable challenge for the limited staff in FDA's device center. But a new automated computer surveillance system should be able to provide needed assistance, scientists from CDRH, Harvard University and other institutions say.
Advertisement

Related Content

FDA’s Latest Post-Market Plan: Data-Mining Device Safety
FDA’s Latest Post-Market Plan: Data-Mining Device Safety … And Then There’s MAUDE
Pilot Programs To Inform Future Studies
ICD Lead Recall Could Have Come Sooner With Novel Surveillance Tool – Study
Sentinel Pilot Begins Scanning Drug Data, But Device Work Still Exploratory
Sentinel Pilot Begins Scanning Drug Data, But Device Work Still Exploratory

Topics

Advertisement
UsernamePublicRestriction

Register

MT029583

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel